Adam R Craig - Net Worth and Insider Trading
Adam R Craig Net Worth
The estimated net worth of Adam R Craig is at least $267,610 dollars as of 2024-05-08. Adam R Craig is the President and CEO of CTI BioPharma Corp and owns about 29,440 shares of CTI BioPharma Corp (CTIC) stock worth over $267,610. Details can be seen in Adam R Craig's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Adam R Craig has not made any transactions after 2023-01-24 and currently still holds the listed stock(s).
Transaction Summary of Adam R Craig
Adam R Craig Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Adam R Craig owns 3 companies in total, including CTI BioPharma Corp (CTIC) , Sunesis Pharmaceuticals Inc (SNSS) , and Viracta Therapeutics Inc (VIRX) .
Click here to see the complete history of Adam R Craig’s form 4 insider trades.
Insider Ownership Summary of Adam R Craig
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CTIC | CTI BioPharma Corp | 2023-01-24 | director & President and CEO |
| SNSS | Sunesis Pharmaceuticals Inc | 2015-02-27 | EVP & Development & CMO |
| VIRX | Viracta Therapeutics Inc | 2012-02-27 | EVP & Development & CMO |
Adam R Craig Latest Holdings Summary
Adam R Craig currently owns a total of 1 stock. Adam R Craig owns 29,440 shares of CTI BioPharma Corp (CTIC) as of January 24, 2023, with a value of $267,610.
Latest Holdings of Adam R Craig
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CTIC | CTI BioPharma Corp | 2023-01-24 | 29,440 | 9.09 | 267,610 |
Holding Weightings of Adam R Craig
Adam R Craig Form 4 Trading Tracker
According to the SEC Form 4 filings, Adam R Craig has made a total of 7 transactions in CTI BioPharma Corp (CTIC) over the past 5 years, including 2 buys and 5 sells. The most-recent trade in CTI BioPharma Corp is the sale of 85,317 shares on January 24, 2023, which brought Adam R Craig around $511,902.
Insider Trading History of Adam R Craig
- 1
Adam R Craig Trading Performance
GuruFocus tracks the stock performance after each of Adam R Craig's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Adam R Craig is 68.4%. GuruFocus also compares Adam R Craig's trading performance to market benchmark return within the same time period. The performance of stocks bought by Adam R Craig within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Adam R Craig's insider trading performs compared to the benchmark.
Performance of Adam R Craig
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 39.99 | | | | | |
| Relative Return to S&P 500(%) | 42.94 | | | | | |
Adam R Craig Ownership Network
Adam R Craig Owned Company Details
What does CTI BioPharma Corp do?
Who are the key executives at CTI BioPharma Corp?
Adam R Craig is the director & President and CEO of CTI BioPharma Corp. Other key executives at CTI BioPharma Corp include EVP & Chief Commercial Officer James K Fong , EVP & Chief Financial Officer David Kirske , and other: See Explanation of Responses Biotechnology Value Fund L P .
CTI BioPharma Corp (CTIC) Insider Trades Summary
Over the past 18 months, Adam R Craig made 2 insider transaction in CTI BioPharma Corp (CTIC) with a net sale of 327,617. Other recent insider transactions involving CTI BioPharma Corp (CTIC) include a net sale of 100,000 shares made by James K Fong , a net sale of 54,042 shares made by David Kirske ,
In summary, during the past 3 months, insiders sold 0 shares of CTI BioPharma Corp (CTIC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 481,659 shares of CTI BioPharma Corp (CTIC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 481,659 shares.
CTI BioPharma Corp (CTIC)'s detailed insider trading history can be found in Insider Trading Tracker table.
CTI BioPharma Corp Insider Transactions
Adam R Craig Mailing Address
Above is the net worth, insider trading, and ownership report for Adam R Craig. You might contact Adam R Craig via mailing address: C/o Innovive Pharmaceuticals, Inc., 555 Madison Avenue, 25th Floor, New York Ny 10022.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
